Abstract
The action of quinidine, procaine amide and five SC-compounds on experimental atrial and ventricular arrhythmias was investigated. The SC-compounds are hydrochlorides of the following bases: SC-3920,N-(γ-isopropylaminopropyl)- α,α-diphenylacetamide; SC-3323, β-diisopropylaminoethyl-4-phenyl-4- tetrahydropyrancarboxylate; SC-3755, o-(4-chlorobenzyl)phenoxyacetamidine; SC-2919, N,N,N'-triphenyl-N'-(β-diethylaminoethyl)urea; and SC-3412, β-diethylaminoethyl-2, 6-dimethyl-5, 6-dihydro-4H-pyran-3-carboxylate. Atrial flutter was produced in dogs by injury and electrical stimulation of the atrium; atrial fibrillation was produced by direct application of aconitine. Ventricular arrhythmias were studied in unanesthetized dogs twenty-four hours after a two-step coronary ligation.
The activity spectrum of the compounds differed and the compounds could be classified as follows: (a) active on atrial and ventricular arrhythmias (quinidine, procaine amide, SC-3920, SC-2919 and SC-3412; (b) active primarily on the atrium (SC-3323); and (c) active primarily on the ventricle (SC-3755). All of the compounds increased the “effective refractory period” of the isolated papillary muscle.
Footnotes
- Received December 15, 1954.
- © 1955, by The Williams & Wilkins Company
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
